ZY * Stock Overview
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Zymergen Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$70.00 |
| 52 Week High | US$71.00 |
| 52 Week Low | US$70.00 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -89.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZY * | MX Chemicals | MX Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -2.7% |
| 1Y | n/a | -16.8% | -2.7% |
Return vs Industry: Insufficient data to determine how ZY * performed against the MX Chemicals industry.
Return vs Market: Insufficient data to determine how ZY * performed against the MX Market.
Price Volatility
| ZY * volatility | |
|---|---|
| ZY * Average Weekly Movement | 0% |
| Chemicals Industry Average Movement | 4.6% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in MX Market | 6.7% |
| 10% least volatile stocks in MX Market | 2.5% |
Stable Share Price: ZY * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ZY *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 505 | n/a | www.zymergen.com |
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries.
Zymergen Inc. Fundamentals Summary
| ZY * fundamental statistics | |
|---|---|
| Market cap | Mex$5.06b |
| Earnings (TTM) | -Mex$7.28b |
| Revenue (TTM) | Mex$290.99m |
17.4x
P/S Ratio-0.7x
P/E RatioIs ZY * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZY * income statement (TTM) | |
|---|---|
| Revenue | US$14.58m |
| Cost of Revenue | US$178.03m |
| Gross Profit | -US$163.45m |
| Other Expenses | US$201.47m |
| Earnings | -US$364.92m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.50 |
| Gross Margin | -1,121.15% |
| Net Profit Margin | -2,503.04% |
| Debt/Equity Ratio | 0% |
How did ZY * perform over the long term?
See historical performance and comparison